Skip to main content

Testopel

NDC 66887-004 · Endo USA, Inc.

Generic nametestosterone
Dosage formPELLET
RouteSUBCUTANEOUS
Active ingredient(s)TESTOSTERONE
Strength75 mg/1
Pharmacologic classAndrogen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
DEA scheduleCIII
Marketing categoryANDA

Packages

66887-004-10 — 10 AMPULE in 1 BOX (66887-004-10) / 1 PELLET in 1 AMPULE (66887-004-01)

66887-004-20 — 100 AMPULE in 1 BOX (66887-004-20) / 1 PELLET in 1 AMPULE (66887-004-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

45802-754 — testosterone, 62332-488 — TESTOSTERONE, 62332-552 — TESTOSTERONE, 63479-1804 — ADENOSINE TRIPHOSPHATE, SILVER, CAMPHOR (NATURAL), BLACK CURRANT, TESTOSTERONE, 63629-2352 — Testosterone, 63629-8455 — testosterone, 63629-9310 — testosterone, 64380-151 — Testosterone, 64380-152 — Testosterone, 66887-001 — testosterone, 66993-951 — testosterone, 66993-952 — testosterone, 66993-953 — testosterone, 66993-954 — testosterone, 66993-955 — testosterone, 68180-941 — Testosterone, 68180-943 — Testosterone, 69097-363 — Testosterone, 69238-1013 — Testosterone, 70700-112 — Testosterone, +32 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels